Acasti Pharma (ACST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 02-2014 | 12-2013 | 11-2013 | 09-2013 | 08-2013 | |
| Sales | 0 | 27 | 0 | 257 | 257 |
| Cost of Goods | N/A | 10 | N/A | 140 | 140 |
| Gross Profit | N/A | 10 | N/A | 110 | 110 |
| Operating Expenses | 0 | 3,200 | 0 | 3,390 | 3,250 |
| Operating Income | N/A | -3,173 | N/A | -3,133 | -3,133 |
| Interest Expense | 0 | 530 | 0 | 1 | 0 |
| Other Income | 0 | 3 | 0 | 14 | 13 |
| Pre-tax Income | 0 | -3,700 | 0 | -3,120 | -3,120 |
| Net Income Continuous | N/A | -3,709 | N/A | -3,122 | -3,122 |
| Net Income | $N/A | $-3,709 | $N/A | $-3,122 | $-3,122 |
| EPS Basic Total Ops | N/A | -24.00 | N/A | -19.20 | -0.40 |
| EPS Basic Continuous Ops | N/A | -21.19 | N/A | -19.48 | -0.41 |
| EPS Diluted Total Ops | N/A | -24.00 | N/A | -19.20 | -0.40 |
| EPS Diluted Continuous Ops | N/A | -21.19 | N/A | -19.48 | -0.41 |
| EBITDA(a) | $N/A | $-2,533 | $N/A | $-2,653 | $-2,653 |